Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis

Carmen González-Olmedo , Francisco José García-Verdejo , Antonio Reguera-Teba , Carmen Rosa-Garrido , José Antonio López-López , Leticia Díaz-Beltrán , Patricia Mena García , Natalia Luque-Caro , Fernando Gálvez-Montosa , Ana Laura Ortega-Granados , María Ruiz-Sanjuan , Antonio Cózar-Ibáñez , Juan Sainz , Juan Antonio Marchal , José Camacho , José Pérez del Palacio , Rosario Fernández-Godino , Caridad Díaz , Pedro Sánchez-Rovira

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1541

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1541 DOI: 10.1002/ctm2.1541
LETTER TO THE JOURNAL

Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis

Author information +
History +
PDF

Cite this article

Download citation ▾
Carmen González-Olmedo, Francisco José García-Verdejo, Antonio Reguera-Teba, Carmen Rosa-Garrido, José Antonio López-López, Leticia Díaz-Beltrán, Patricia Mena García, Natalia Luque-Caro, Fernando Gálvez-Montosa, Ana Laura Ortega-Granados, María Ruiz-Sanjuan, Antonio Cózar-Ibáñez, Juan Sainz, Juan Antonio Marchal, José Camacho, José Pérez del Palacio, Rosario Fernández-Godino, Caridad Díaz, Pedro Sánchez-Rovira. Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis. Clinical and Translational Medicine, 2024, 14(1): e1541 DOI:10.1002/ctm2.1541

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

160

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/